Clenbuterol
Brand names: Ventipulmin ยท Active ingredient: Clenbuterol Hydrochloride
โ Boxed warning (FDA's strongest warning)
The effect on reproduction in breeding stallions and brood mares has not been determined. Treatment starting with dosages higher than the initial dose is not recommended.
Not for use in humans. Do not use in horses intended for human consumption. Keep out of reach of children. In case of accidental ingestion, contact a physician immediately. Ingestion of VENTIPULMIN Syrup may cause undesirable reactions. Clenbuterol, like other beta adrenergic agonists, can produce significant cardiovascular effects in some people as evidenced by elevated pulse rate, blood pressure changes and/or ECG changes.
Clenbuterol dosage
Administer orally twice a day (b.i.d.). Initial dose is 0.5 mL/100 lbs body weight (0.8 mcg/kg) twice daily.
Initial dosage: administer 0.5 mL/100 lbs (0.8 mcg/kg) for 3 days (6 treatments); If no improvement, administer 1.0 mL/100 lbs (1.6 mcg/kg) for 3 days (6 treatments); If no improvement, administer 1.5 mL/100 lbs (2.4 mcg/kg) for 3 days (6 treatments); If no improvement, administer 2.0 mL/100 lbs (3.2 mcg/kg) for 3 days (6 treatments); If no improvement, horse is non-responsive to clenbuterol and treatment should be discontinued. Recommended duration of treatment at effective dose is 30 days. At the end of this 30-day treatment period, drug should be withdrawn to determine recurrence of signs. If signs return, the 30-day treatment regimen may be repeated. If repeating treatment, the step-wise dosage schedule should be repeated.
Lbs. Body
Weight | mL/treatment
at 0.5 mL/100#
(0.8 mcg/kg) | mL/treatment
at 1.0 mL/100#
(1.6 mcg/kg) | mL/treatment
at 1.5 mL/100#
(2.4 mcg/kg) | mL/treatment
at 2.0 mL/100#
(3.2 mcg/kg)
500
600
700
800
900
1000
1100
1200
1300
1400
1500
1600
1700
1800 | 2.5
3.0
3.5
4.0
4.5
5.0
5.5
6.0
6.5
7.0
7.5
8.0
8.5
9.0 | 5.0
6.0
7.0
8.0
9.0
10.0
11.0
12.0
13.0
14.0
15.0
16.0
17.0
18.0 | 7.5
9.0
10.5
12.0
13.5
15.0
16.5
18.0
19.5
21.0
22.5
24.0
25.5
27.0 | 10.0
12.0
14.0
16.0
18.0
20.0
22.0
24.0
26.0
28.0
30.0
32.0
34.0
36.0
Administer two treatments per day.
Warnings & precautions
Do not take this medicine if: VENTIPULMIN Syrup antagonizes the effects of prostaglandin F2 ฮฑ and oxytocin. VENTIPULMIN Syrup should not be used in pregnant mares near term. Because tachycardia may occur, VENTIPULMIN Syrup should not be used in horses suspected of having cardiovascular impairment.
Clenbuterol side effects
Mild sweating, muscle tremor, restlessness, urticaria and tachycardia may be observed in some horses during the first few days of treatment. May cause elevated creatine kinase (CK) serum levels. Ataxia was observed in 3 out of 239 horses (1.3%) in clinical studies. To report suspected adverse events, for technical assistance, or to obtain a copy of the Safety Data Sheet (SDS), contact Boehringer Ingelheim Animal Health USA Inc. at 1-888-637-4251. For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDA-VETS or online at www.fda.gov/reportanimalae.
About this medicine
Clenbuterol (4-amino-alpha-[(tert-butylamino) methyl]-3, 5-dichlorobenzyl alcohol hydrochloride) is a beta-2-adrenergic agonist which provides bronchodilating properties as well as other effects, with minimum effect on the cardiovascular system. It is provided as a colorless, palatable syrup. VENTIPULMIN Syrup (clenbuterol hydrochloride) is antagonized by beta-adrenergic blocking agents.
Source: FDA-approved label via DailyMed (U.S. National Library of Medicine), label set ID 691e6c6a-0ac6-4cc2-bd87-954bf6716735. Read the full official label on DailyMed.